Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
Prescription Information Dissemination OK’d
Associated Press, December 24, 2007
A federal judge in Maine recently overturned a new state law that restricts access by medical data companies to doctors’ prescription information.
U.S. District Judge John Woodcock concluded that the law, which was scheduled to take effect Jan. 1, would prohibit “the transfer of truthful commercial information” and “violate the free speech guarantee of the First Amendment.”
The law had been challenged on constitutional grounds by IMS Health Inc. of Norwalk, Conn., Wolters Kluwer Health of Conshohocken, Pa., and Verispan of Yardley, Pa., which collect, analyze and sell medical data to pharmaceutical companies for use in their marketing programs.
Judge Woodcock noted that he relied heavily on an April 30 ruling by a U.S. District Judge in New Hampshire that shot down a similar law in that state, while a similar case is pending in Vermont.
And so, what is your opinion on physician prescription information privacy? Will other states follow Maine?
Share this:
Filed under: Information Technology | Tagged: Big Pharma and Drugs |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Leave a comment